Optimization, validation, and application of LC-(QqQ)MS/MS for the determination and occurrence of new drugs of abuse in wastewater samples by Borova, Viola L. et al.
9/11/2014
1
Optimization, validation, and 
application of 
LC-(QqQ)MS/MS for the 
determination and occurrence of 
new drugs of abuse in wastewater 
samples 
Viola L. Borova 




What are “New Designer Drugs”
Designer Drugs:
§ Synthetically changed natural substances
§ Completely designed molecular structures
§ Psychotropic effects
New Designer Psychotropic Drugs:
§ Drug alternatives
§ Optimized effects of already existing drugs
Ø Higher binding affinity with CB1, greater potency and adverse
effects and longer duration of action
§ Not covered in most countries by controlled substance
statutes
Ø avoid detection and legal consequences
§ “Spice” drugs (smoking mixtures, herbal mixtures), bath




















Classes of New Designer Drugs
Phenylalkylamines
• Beta-keto (mephedrone, butylone (bk-MBDB), 
methylone (bk-MDMA)
Piperazines
• Phenylpiperazine (DCPP, mCPP, MeOPP, pCPP, 
TFMPP)
• Benzylpiprazine (BZP, MBZP, DBZP, MDBZP)
Synthetic Cannabinoids
• JWH cannabinoids (John W. Huffman), 
• (JWH 018, JWH 073 aminoalkylindoles series 
and more than 400 cannabinoids)
• CP47, 497 (From Pfizer, cyclohexylphenol
series) (analog CP47,497 and homologue 
C6,C7,C8,C9) 
Pyrrolidinophenones


























New Designer Drugs… a new class of emerging organic 
contaminants
§Not currently covered by existing water quality regulations
§Not investigated or little 
§Newly identified or previously unrecognized
§Lack of environmental data
§Lack of analytical methods in wastewater
§Large volume of consumption and production


































Thermo Scientific Quantum Access




































C21H34O2 318.5 6.17 -
Mephedrone / 
Mephedrone D3
C11H15NO 177.2 2.12 8.69
Benzylpiperazine
/BZP D7












































Method Development and Optimization of MS/MS











127.0 (45V) 80.1 +
JWH-073 328.1 154.9 (25V)127.0 (43V) 76.3 +
CP47,497 317.2 298.9 (24V)244.7 (34V) 99.1 -




148.0 (21V) 49.0 +
BZP 177.1 91.2 (28V)65.3 (40V) 62.5 +
BZP D7 184.1 98.2 (27V)70.3 (40V) 66.3 +













































Comparison of stationary phases  
Stationary phases: Atlantis T3 (C18) (Waters), 
XSelect (C18) (Waters) & PFP (Phenomenex)
RT: 0.00 - 30.00






































20.6013.51 27.973.97 17.7314.084.67 24.6823.6412.775.98 9.190.60
NL:
1.26E7





RT: 0.00 - 30.00









































9.55 11.12 17.92 23.2422.05 26.8924.24 27.771.00
NL:
1.04E7




R T: 0 .0 0 - 30 .0 0
0 2 4 6 8 10 12 14 16 18 20 2 2 24 2 6 2 8 30
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vCompounds with –NH2 or –NH-
presented higher asymmetry
(fronting) on C18 column
vXselect and Atlantis T3 suffer
from peak shape issues and do not
provide good separation of the
compounds
vPFP: excellent peak shape, good
resolution and separation in short

















§ I I I  
 
Mobile Phase   
Positive H2O (0.2% 
formic acid)
MeOH μL/min
0.00 60 40 100
3.00 60 40 150
15.00 0.0 100 100
25.00 0.0 100 100
25.50 60 40 100
30.00 60 40 100
Negative MeOH ACN μL/min
0.00 90 10 100
3.00 90 10 100
15.00 90 10 100























Effect of the organic modifier   
RT:0.00 - 30.00













































































AA: 9603 RT: 19.50
AA: 7214
RT: 14.33
AA: 6833 RT: 20.42
AA: 3647
RT: 9.18






















RT:0.0  - 30.00














































































































































































































































R T: 0 .0 0 - 30 .00
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28

































AA: 38 66 38
R T : 5 .55
AA: 18 775 4
R T : 1 6.9 9
AA: 13 583 5
R T : 2.8 6
AA: 89 19 0
R T: 5.70
AA: 1 18 135
R T : 16.77
AA: 92 48 8
R T: 16 .76
AA: 7 82 48
R T: 5.4 3
AA: 9 169 1
R T: 2.9 3
AA: 9 270 3 R T : 1 0.22
AA: 43 90 0R T : 5 .8 1AA: 75 356
R T: 10 .43
AA: 3 099 7
R T: 17 .0 6
AA: 4 75 05
R T: 5.9 3
AA: 4 802 1
R T: 2.7 7
AA: 20 42 2
R T: 17 .10
AA: 2 709 3
R T: 10.61
AA: 18 60 2R T : 6 .1 5
AA: 22 569 R T: 14 .46
AA: 9 17 5
R T: 17 .2 2
AA: 1 10 11
R T: 10 .99
AA: 7 43 4
R T : 2 .7 3
AA: 60 38
R T : 5.2 8
AA: 92 33
R T: 6.98
AA: 3 91 9
R T: 2.7 0
AA: 1 888 R T : 29.88
AA: 56 6
R T: 16 .0 5
AA: 1 44 34
R T: 16 .0 6
AA: 4 94
R T: 19 .71
AA: 5 35
R T: 23 .1 1
AA: 3 55
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26.37 28.5318.381.86 10.489.043.04 5.39 8.316.84 11.260.66 14.00 16.87
RT: 19.50
NL: 7.68E4
Base Peak m/z= 
118.6 0-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900- 119.300, 









































15.10 16.453.30 18.57 28.4611.418.246.555.71 9.09 23.05 25.341.22 20.68 26.17
RT: 12.36
NL: 3.37E5
Base Peak m/z= 






































12.69 13.74 15.768.48 17.94 19.77 24.395.48 6.19 21.139.16 28.334.400.51 2.91 26.06
RT: 11.13
NL: 4.58E5
Base Peak m/z= 




































12.04 13.23 15.01 16.37 29.006.38 7.694.27 20.073.50 21.490.33 23.57 26.8224.39
RT: 10.22
NL: 4.73E5
Bas e Peak m/z= 
118.60-119.60 F: + c ESI SRM 
ms2 218.100 
[118.900-119.300, 

















11.48 12.67 14.046.60 8.64
RT: 9.79

































§ I I I  
 











































Sample preparation  
1. Wastewater samples were 
filtered on Glass fiber filters 
2. 50 mL of filtrated sample were 
adjusted at a value of pH 2.5 
with HCl (1 M)
3. Internal deuterated standards 
of the compounds were added 
to all samples
4. SPE (STRATA-X/ISOLUTE 
C18, STATA-XC)
Reconstitution :
500 μL of 40% MeOH and 
60% ultra purified water 
































BZP 1 – 100 0.9993 4.8 29.0 14.8
Mephedrone 1 – 100 0.9994 0.3 100 3.7
MPPP 1 – 100 0.9994 0.6 99.0 4.2
CP47,497 1 – 100 0.9991 37 97.0 15.2
JWH 018 1 – 100 0.9991 1.4 40.0 8.3













































üFlow rate: 1500 m3/day



































•BZP → <LOD – 17.8 ng/L
•Mephedrone → 1.5 – 4.0 ng/L
•MPPP → <LOD ng/L
•CP47→ 179 – 1469 ng/L
•JWH 018→ <LOD – 2.2 ng/L
•JWH 073→ <LOD – 1.0 ng/L
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Levels in influent wastewater of Fira













































ü Development and validation of a novel 
method for new designer drugs in 
wastewater by LC-MS/MS 
üInvestigation of their occurrence in a 
WWTP in Santorini Island
ü5 out of the 6 compounds were detected at 
least in one day 
üCP47 was detected for the first time in 
influent wastewater
üNot any special trend among the days was 
















CONCLUSIONSC CL SI S
Future Perspectives
üIntegration into one multi-analyte method 
which provides the elution of all the 
compounds with one cartridge 
üIdentification of their transformation 
products
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